334 related articles for article (PubMed ID: 16862449)
1. The Trk tyrosine kinase inhibitor K252a regulates growth of lung adenocarcinomas.
Perez-Pinera P; Hernandez T; García-Suárez O; de Carlos F; Germana A; Del Valle M; Astudillo A; Vega JA
Mol Cell Biochem; 2007 Jan; 295(1-2):19-26. PubMed ID: 16862449
[TBL] [Abstract][Full Text] [Related]
2. Fine-tuning roles of endogenous brain-derived neurotrophic factor, TrkB and sortilin in colorectal cancer cell survival.
Akil H; Perraud A; Mélin C; Jauberteau MO; Mathonnet M
PLoS One; 2011; 6(9):e25097. PubMed ID: 21966426
[TBL] [Abstract][Full Text] [Related]
3. Neurotrophin signaling via TrkB and TrkC receptors promotes the growth of brain tumor-initiating cells.
Lawn S; Krishna N; Pisklakova A; Qu X; Fenstermacher DA; Fournier M; Vrionis FD; Tran N; Chan JA; Kenchappa RS; Forsyth PA
J Biol Chem; 2015 Feb; 290(6):3814-24. PubMed ID: 25538243
[TBL] [Abstract][Full Text] [Related]
4. Signal transduction pathways through TRK-A and TRK-B receptors in human neuroblastoma cells.
Sugimoto T; Kuroda H; Horii Y; Moritake H; Tanaka T; Hattori S
Jpn J Cancer Res; 2001 Feb; 92(2):152-60. PubMed ID: 11223544
[TBL] [Abstract][Full Text] [Related]
5. Endogenous neurotrophins and Trk signaling in diffuse large B cell lymphoma cell lines are involved in sensitivity to rituximab-induced apoptosis.
Bellanger C; Dubanet L; Lise MC; Fauchais AL; Bordessoule D; Jauberteau MO; Troutaud D
PLoS One; 2011; 6(11):e27213. PubMed ID: 22076137
[TBL] [Abstract][Full Text] [Related]
6. Rational basis for Trk inhibition therapy for prostate cancer.
Weeraratna AT; Arnold JT; George DJ; DeMarzo A; Isaacs JT
Prostate; 2000 Oct; 45(2):140-8. PubMed ID: 11027413
[TBL] [Abstract][Full Text] [Related]
7. Autocrine regulation of nerve growth factor expression by Trk receptors.
Mallei A; Rabin SJ; Mocchetti I
J Neurochem; 2004 Sep; 90(5):1085-93. PubMed ID: 15312164
[TBL] [Abstract][Full Text] [Related]
8. Rapid stimulatory effects of brain-derived neurotrophic factor and neurotrophin-3 on somatostatin release and intracellular calcium rise in primary hypothalamic cell cultures.
Marmigère F; Choby C; Rage F; Richard S; Tapia-Arancibia L
Neuroendocrinology; 2001 Jul; 74(1):43-54. PubMed ID: 11435757
[TBL] [Abstract][Full Text] [Related]
9. Retrograde transport of neurotrophins from the eye to the brain in chick embryos: roles of the p75NTR and trkB receptors.
von Bartheld CS; Williams R; Lefcort F; Clary DO; Reichardt LF; Bothwell M
J Neurosci; 1996 May; 16(9):2995-3008. PubMed ID: 8622129
[TBL] [Abstract][Full Text] [Related]
10. Anti-apoptotic role and clinical relevance of neurotrophins in diffuse large B-cell lymphomas.
Dubanet L; Bentayeb H; Petit B; Olivrie A; Saada S; de la Cruz-Morcillo MA; Lalloué F; Gourin MP; Bordessoule D; Faumont N; Delage-Corre M; Fauchais AL; Jauberteau MO; Troutaud D
Br J Cancer; 2015 Sep; 113(6):934-44. PubMed ID: 26284337
[TBL] [Abstract][Full Text] [Related]
11. Neurotrophins and Trk receptors in primitive neuroectodermal tumor cell lines.
Chiappa SA; Chin LS; Zurawel RH; Raffel C
Neurosurgery; 1999 Nov; 45(5):1148-54; discussion 1154-5. PubMed ID: 10549931
[TBL] [Abstract][Full Text] [Related]
12. Expression of neurotrophins and their receptors in the mammalian ovary is developmentally regulated: changes at the time of folliculogenesis.
Dissen GA; Hirshfield AN; Malamed S; Ojeda SR
Endocrinology; 1995 Oct; 136(10):4681-92. PubMed ID: 7664689
[TBL] [Abstract][Full Text] [Related]
13. Neurotrophin receptor expression in human primary retinoblastomas and retinoblastoma cell lines.
Stephan H; Zakrzewski JL; Bölöni R; Grasemann C; Lohmann DR; Eggert A
Pediatr Blood Cancer; 2008 Feb; 50(2):218-22. PubMed ID: 17973327
[TBL] [Abstract][Full Text] [Related]
14. Neurotrophins and neurotrophin receptors in human lung cancer.
Ricci A; Greco S; Mariotta S; Felici L; Bronzetti E; Cavazzana A; Cardillo G; Amenta F; Bisetti A; Barbolini G
Am J Respir Cell Mol Biol; 2001 Oct; 25(4):439-46. PubMed ID: 11694449
[TBL] [Abstract][Full Text] [Related]
15. Expression of functional TrkA receptor tyrosine kinase in the HMC-1 human mast cell line and in human mast cells.
Tam SY; Tsai M; Yamaguchi M; Yano K; Butterfield JH; Galli SJ
Blood; 1997 Sep; 90(5):1807-20. PubMed ID: 9292513
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of brain-derived neurotrophic factor/tyrosine kinase B signaling suppresses choriocarcinoma cell growth.
Kawamura N; Kawamura K; Manabe M; Tanaka T
Endocrinology; 2010 Jul; 151(7):3006-14. PubMed ID: 20463055
[TBL] [Abstract][Full Text] [Related]
17. Differential dependency of cutaneous mechanoreceptors on neurotrophins, trk receptors, and P75 LNGFR.
Fundin BT; Silos-Santiago I; Ernfors P; Fagan AM; Aldskogius H; DeChiara TM; Phillips HS; Barbacid M; Yancopoulos GD; Rice FL
Dev Biol; 1997 Oct; 190(1):94-116. PubMed ID: 9331334
[TBL] [Abstract][Full Text] [Related]
18. Trk receptors need neutral sphingomyelinase activity to promote cell viability.
Candalija A; Cubí R; Ortega A; Aguilera J; Gil C
FEBS Lett; 2014 Jan; 588(1):167-74. PubMed ID: 24316227
[TBL] [Abstract][Full Text] [Related]
19. Neurotrophin effects on neuroblastoma cells: correlation with trk and p75NTR expression and influence of Trk receptor bodies.
Evangelopoulos ME; Weis J; Kruttgen A
J Neurooncol; 2004 Jan; 66(1-2):101-10. PubMed ID: 15015775
[TBL] [Abstract][Full Text] [Related]
20. Brain-derived neurotrophic factor and neurotrophin-4/5 are expressed in breast cancer and can be targeted to inhibit tumor cell survival.
Vanhecke E; Adriaenssens E; Verbeke S; Meignan S; Germain E; Berteaux N; Nurcombe V; Le Bourhis X; Hondermarck H
Clin Cancer Res; 2011 Apr; 17(7):1741-52. PubMed ID: 21350004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
